Kazuo Nishimura

Osaka International Cancer Institute — Japan

Medicine · Health Sciences

38h-index6.4kcitations438works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(79), Renal cell carcinoma treatment(56), Bladder and Urothelial Cancer Treatments(53), Prostate Cancer Diagnosis and Treatment(31), Testicular diseases and treatments(28)

Publications433 total

Adverse Events in Testicular Cancer Survivors Using EORTC QLQ‐TC26: A Multi‐Institutional, Cross‐Sectional Study in Japan
International Journal of Urology·2025
Adaptive kernel-density approach for imbalanced binary classification
arXiv (Cornell University)·2025Open Access
Trends in real-world outcomes of patients with metastatic renal cell cancer in the recent treatment era: a single-institution analysis
International Journal of Clinical Oncology·2025
Trends in real-world outcomes of patients with metastatic renal cell cancer in the recent treatment era: A single institution analysis
2025Open Access
Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration‐Resistant Prostate Cancer: <scp>PROpel</scp> Subset Analysis
Cancer Science·2025Open Access
Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First‐Line Treatment in Patients With Metastatic Castration‐Resistant Prostate Cancer: <scp>TALAPRO</scp> ‐2 Japanese Subgroup Analysis
Cancer Medicine·2024· 1 citedOpen Access
Risk assessment of late biochemical recurrence after radical prostatectomy: Usefulness of ultra‐sensitive prostate‐specific antigen measurement
International Journal of Urology·2024· 1 cited
Comorbidities in Japanese testicular cancer survivors: A multi‐institutional, cross‐sectional study
International Journal of Urology·2024· 1 citedOpen Access
Clinical outcomes of first-line combination therapy with immune checkpoint inhibitor for metastatic non-clear cell renal cell carcinoma: a multi-institutional retrospective study in Japan
International Journal of Clinical Oncology·2024· 6 citedOpen Access
Real‐world assessment of comprehensive genome profiling impact on clinical outcomes: A single‐institution study in Japan
Cancer Medicine·2024· 5 citedOpen Access
The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab
Clinical and Experimental Medicine·2024· 4 citedOpen Access
Metastatic castration resistant prostate cancer patients’ experience with Radium-223 treatment in Japan
Future Oncology·2024· 2 citedOpen Access
The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab
2024Open Access
Outcomes in patients with high- and very high-risk localized prostate cancer treated with definitive IMRT and long-term hormone therapy
Japanese Journal of Clinical Oncology·2023· 1 cited
MO25-4 Clinical outocomes of nivolumab plus ipilimumab in metastatic renal cell carinoma
Annals of Oncology·2023Open Access
Relapsing cytokine release syndrome in a patient with metastatic renal cell carcinoma treated with pembrolizumab and axitinib therapy
International Cancer Conference Journal·2023· 1 citedOpen Access
Sexual function using the EORTC QLQ‐TC26 in testicular cancer survivors: A multi‐institutional, cross‐sectional study
International Journal of Urology·2023· 6 cited
Management of bone metastasis in prostate cancer
Journal of Bone and Mineral Metabolism·2023· 12 cited
[A Case of Primary Signet Ring Cell Carcinoma of the Urinary Bladder Showing Effectiveness of Chemotherapy with Gemcitabine and Cisplatin].
PubMed·2023· 1 cited
A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
BMC Urology·2023· 7 citedOpen Access
page 1 of 22Next →

Frequent Co-authors

Norio Nonomura(22), Äkïhïko Okuyama(14), Masashi Nakayama(12), Yasutomo Nakai(11), Hitoshi Takayama(8), Daizo Oka(8), Tsuneharu Miki(6), Shuyuan Yeh(5), Akira Tsujimura(5), Hitoshi Inoue(5), Atsunari Kawashima(5), Akira Nagahara(5), Jae‐Lyun Lee(4), Satoshi Fukasawa(4), Hiroshi Miyamoto(4), Hong‐Yo Kang(4), Chawnshang Chang(4), Natsuki Takaha(4), Yasuyuki Arai(4), Masatoshi Mukai(4)